ZA955025B - L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatose - Google Patents
L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoseInfo
- Publication number
- ZA955025B ZA955025B ZA955025A ZA955025A ZA955025B ZA 955025 B ZA955025 B ZA 955025B ZA 955025 A ZA955025 A ZA 955025A ZA 955025 A ZA955025 A ZA 955025A ZA 955025 B ZA955025 B ZA 955025B
- Authority
- ZA
- South Africa
- Prior art keywords
- dermatose
- cosmetic
- treating
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM940396A IT1272290B (it) | 1994-06-20 | 1994-06-20 | Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA955025B true ZA955025B (en) | 1996-02-08 |
Family
ID=11402602
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA955024A ZA955024B (en) | 1994-06-20 | 1995-06-19 | L-carnitine salt and compositions containing same |
ZA955025A ZA955025B (en) | 1994-06-20 | 1995-06-19 | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatose |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA955024A ZA955024B (en) | 1994-06-20 | 1995-06-19 | L-carnitine salt and compositions containing same |
Country Status (13)
Country | Link |
---|---|
US (1) | US5591450A (ko) |
EP (2) | EP0688761A2 (ko) |
JP (2) | JPH0827081A (ko) |
KR (2) | KR960000855A (ko) |
AT (1) | ATE165338T1 (ko) |
CA (2) | CA2150407A1 (ko) |
DE (1) | DE69502147T2 (ko) |
ES (1) | ES2116651T3 (ko) |
HK (1) | HK1004918A1 (ko) |
IT (1) | IT1272290B (ko) |
PH (1) | PH31606A (ko) |
TW (1) | TW300881B (ko) |
ZA (2) | ZA955024B (ko) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1272290B (it) * | 1994-06-20 | 1997-06-16 | Avantgarde Spa | Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee |
AUPN115095A0 (en) * | 1995-02-15 | 1995-03-09 | Butt, Henry Lawrence | Analysis of and compositions and methods for the treatment of disease |
IT1276253B1 (it) | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi |
IT1289974B1 (it) * | 1997-02-25 | 1998-10-19 | Aldo Fassi | Procedimento per la produzione di sali stabili e non igroscopici di l(-)carnitina e di alcanoli l(-)-carnitine |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
US6080788A (en) * | 1997-03-27 | 2000-06-27 | Sole; Michael J. | Composition for improvement of cellular nutrition and mitochondrial energetics |
US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
US5863940A (en) | 1997-12-01 | 1999-01-26 | Sigma-Tau Healthscience S.P.A. | Medicament and therapeutical method for treating idiopathic asthenozoospermia |
SI0951909T2 (sl) | 1998-03-19 | 2010-11-30 | Sigma Tau Ind Farmaceuti | Kombinirana zmes ki vsebuje L karnitin ali alkanoil L karnitin glikozaminoglikan in ali njegov sestavni del |
KR20000050756A (ko) * | 1999-01-14 | 2000-08-05 | 연규 | 핀 귀걸이의 제조방법과 그 제품의 구조 |
US6090849A (en) * | 1999-03-23 | 2000-07-18 | The Board Of Regents For Oklahoma State University | Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry |
ITRM20010364A1 (it) * | 2001-06-25 | 2002-12-27 | Biosalts Srl | Ascorbil derivati di carnitine e composizioni cosmetiche contenenti tali derivati. |
EP1610760A4 (en) * | 2003-03-28 | 2008-01-09 | Lonza Ag | TOPICAL COMPOSITIONS OF L-CARNITINE |
JP4539096B2 (ja) * | 2004-01-16 | 2010-09-08 | 日油株式会社 | 油性成分被覆l−カルニチン塩粉末およびその用途 |
CN1322860C (zh) * | 2004-08-31 | 2007-06-27 | 北京正大绿洲医药科技有限公司 | 左旋肉碱滴丸及其制备方法 |
US7572832B2 (en) * | 2007-03-19 | 2009-08-11 | Biolink Life Sciences, Inc. | Non-hygroscopic L-carnitine salts |
KR101633846B1 (ko) | 2013-11-25 | 2016-06-27 | 주식회사 엘지화학 | 도전성 패턴 형성용 조성물 및 도전성 패턴을 갖는 수지 구조체 |
US10118911B2 (en) * | 2015-03-27 | 2018-11-06 | Jiangsu Hengrui Medicine Co., Ltd. | P-toluenesulfonate for MEK kinase inhibitor, and crystal form thereof and preparation method therefor |
CN107216339B (zh) * | 2016-03-22 | 2021-05-04 | 中国科学院上海药物研究所 | 一种dppiv抑制剂马来酸盐的多晶型及其制备方法 |
CN107216340B (zh) * | 2016-03-22 | 2021-05-04 | 中国科学院上海药物研究所 | 一种dppiv抑制剂的盐型及其制备方法 |
SE542106C2 (en) * | 2016-08-26 | 2020-02-25 | Atif M Dabdoub | Dietary macro/micronutritional supplement for patients undergoing kidney dialysis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3463261D1 (en) | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
FR2627385B3 (fr) * | 1988-02-23 | 1991-08-23 | Serobiologiques Lab Sa | Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques |
US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
US5137910A (en) * | 1989-05-05 | 1992-08-11 | C.D. Searle & Co. | Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders |
IT1263013B (it) * | 1992-10-20 | 1996-07-23 | Avantgarde Spa | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. |
IT1261984B (it) * | 1993-06-22 | 1996-06-11 | Avantgarde Spa | Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
IT1272290B (it) * | 1994-06-20 | 1997-06-16 | Avantgarde Spa | Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee |
-
1994
- 1994-06-20 IT ITRM940396A patent/IT1272290B/it active IP Right Grant
-
1995
- 1995-05-18 EP EP95830209A patent/EP0688761A2/en not_active Withdrawn
- 1995-05-29 CA CA002150407A patent/CA2150407A1/en not_active Abandoned
- 1995-06-02 KR KR1019950014607A patent/KR960000855A/ko not_active Application Discontinuation
- 1995-06-07 US US08/473,208 patent/US5591450A/en not_active Expired - Fee Related
- 1995-06-12 ES ES95109027T patent/ES2116651T3/es not_active Expired - Lifetime
- 1995-06-12 EP EP95109027A patent/EP0697397B1/en not_active Expired - Lifetime
- 1995-06-12 AT AT95109027T patent/ATE165338T1/de not_active IP Right Cessation
- 1995-06-12 DE DE69502147T patent/DE69502147T2/de not_active Expired - Fee Related
- 1995-06-13 PH PH50702A patent/PH31606A/en unknown
- 1995-06-16 CA CA002152005A patent/CA2152005A1/en not_active Abandoned
- 1995-06-16 KR KR1019950015962A patent/KR960000217A/ko not_active Application Discontinuation
- 1995-06-19 ZA ZA955024A patent/ZA955024B/xx unknown
- 1995-06-19 ZA ZA955025A patent/ZA955025B/xx unknown
- 1995-06-19 JP JP7151457A patent/JPH0827081A/ja active Pending
- 1995-06-20 TW TW084106325A patent/TW300881B/zh active
- 1995-06-20 JP JP7153148A patent/JPH0826984A/ja active Pending
-
1998
- 1998-05-09 HK HK98104024A patent/HK1004918A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR960000217A (ko) | 1996-01-25 |
CA2152005A1 (en) | 1995-12-21 |
IT1272290B (it) | 1997-06-16 |
EP0688761A3 (ko) | 1996-01-17 |
EP0697397A1 (en) | 1996-02-21 |
ZA955024B (en) | 1996-02-08 |
DE69502147T2 (de) | 1998-08-13 |
US5591450A (en) | 1997-01-07 |
DE69502147D1 (de) | 1998-05-28 |
EP0688761A2 (en) | 1995-12-27 |
ATE165338T1 (de) | 1998-05-15 |
HK1004918A1 (en) | 1998-12-11 |
KR960000855A (ko) | 1996-01-25 |
TW300881B (ko) | 1997-03-21 |
EP0697397B1 (en) | 1998-04-22 |
ITRM940396A1 (it) | 1995-12-20 |
PH31606A (en) | 1998-11-03 |
ES2116651T3 (es) | 1998-07-16 |
CA2150407A1 (en) | 1995-12-21 |
ITRM940396A0 (it) | 1994-06-20 |
JPH0826984A (ja) | 1996-01-30 |
JPH0827081A (ja) | 1996-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA955025B (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatose | |
HU227841B1 (en) | 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof | |
HUP9800462A3 (en) | Arylsulfonylamino hydroxamic acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
GB9410987D0 (en) | High dosage pharmaceutical compositions | |
IL116674A0 (en) | A microcrystalline cellulose-based excipient having improved compressibility solid dosage form pharmaceutical compositions containing the same and methods for the preparation thereof | |
HRP960558B1 (en) | New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them | |
HUP0000214A3 (en) | Alpha-substituted benzenesulphonamido hydroxamic acids, process for their preparation and pharmaceutical compositions containing them | |
HUP9603495A2 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
IL109703A0 (en) | Substituted carbazole derivatives, processes for their preparation and pharmaceutical compositions containing them | |
IL107653A0 (en) | N,n-disubstituted arylcycloalkylamines their preparation and pharmaceutical compositions containing them | |
IL119080A0 (en) | Pharmaceutical compositions containing tramadol | |
IL98864A0 (en) | Oxazolyl derivatives,process for their preparation and pharmaceutical compositions containing them | |
HUP9801880A3 (en) | Novel cryptophycins, their use and pharmaceutical compositions containing them | |
HU9800512D0 (en) | Salts of bismuthum and antibiotica of the moenomycin group, process for producing them, their use and pharmaceutical compositions containing them | |
ZA911804B (en) | 1-azabicyclic compounds,processes and pharmaceutical compositions containing them | |
EP0515995A3 (en) | N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them | |
IL88998A0 (en) | Novel amino acid glycerides,processes for their preparation,and pharmaceutical compositions containing them | |
IL98260A0 (en) | Hiv protease inhibiting oligopeptides,process for their preparation and pharmaceutical compositions containing them | |
IL98576A0 (en) | Amino acid derivatives,their manufacture and pharmaceutical compositions containing them | |
NZ239222A (en) | Pharmaceutical capsules and tablets containing ifosfamide | |
HUP9801068A3 (en) | 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them | |
CA2067275A1 (en) | Pharmaceutical formulation containing dirithromycin | |
IL109430A0 (en) | Hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them | |
ZA963350B (en) | Cycloheaxane compounds process for their preparation and pharmaceutical compositions containing them | |
HUP9802571A3 (en) | Pyridiniminyl-1,2-benzisoxazoles and- benzisothiazoles, process for their preparation and pharmaceutical compositions containing them |